Junli Hao
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Hepatology top 5%
- Hepatitis C virus research
Papers in
-
- Circular RNAs in diseases 4
- Extracellular vesicles in disease 2
-
- MicroRNA in disease regulation 9
- Cancer-related molecular mechanisms research 6
- Co-authors
- Songdong Meng (7 shared papers)Changfei Li (7 shared papers)Saifeng Wang (3 shared papers)Jun Hu (3 shared papers)Yaxing Xu (2 shared papers)Lizhao Chen (3 shared papers)Ying Ju (2 shared papers)Hongxia Fan (3 shared papers)
In The Last Decade
Junli Hao
24 papers receiving 564 citations
Peers
Comparison fields: 5 of 79
- Cancer Research 306
- Hepatology 130
- Molecular Biology 350
- Epidemiology 173
- Immunology 45
Countries citing papers authored by Junli Hao
This map shows the geographic impact of Junli Hao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junli Hao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junli Hao more than expected).
Fields of papers citing papers by Junli Hao
This network shows the impact of papers produced by Junli Hao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junli Hao. The network helps show where Junli Hao may publish in the future.
Co-authors
The 25 scholars most cited alongside Junli Hao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 172 | |
| 2 | 2012 | 125 | |
| 3 | 2016 | 54 | |
| 4 | 2012 | 42 | |
| 5 | 2016 | 36 | |
| 6 | 2014 | 29 | |
| 7 | 2023 | 20 | |
| 8 | 2016 | 16 | |
| 9 | 2022 | 14 | |
| 10 | 2022 | 10 | |
| 11 | 2022 | 8 | |
| 12 | 2016 | 8 | |
| 13 | 2023 | 6 | |
| 14 | 2023 | 5 | |
| 15 | 2023 | 4 | |
| 16 | 2022 | 4 | |
| 17 | 2024 | 4 | |
| 18 | 2015 | 4 | |
| 19 | 2024 | 3 | |
| 20 | 2021 | 3 |
About Junli Hao
Junli Hao is a scholar working on Molecular Biology, Cancer Research, Epidemiology, Cardiology and Cardiovascular Medicine and Hepatology, having authored 26 papers that have together received 572 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (9 papers), Cancer-related molecular mechanisms research (6 papers), Hepatitis B Virus Studies (4 papers), Circular RNAs in diseases (4 papers), Hepatitis C virus research (3 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Liver Disease Diagnosis and Treatment (2 papers) and Extracellular vesicles in disease (2 papers). The work is most often cited by research in Cancer Research (306 citations), Hepatology (130 citations), Molecular Biology (350 citations), Epidemiology (173 citations) and Immunology (45 citations). Junli Hao has collaborated with scholars based in China, Australia and Hong Kong. Frequent co-authors include Songdong Meng, Changfei Li, Saifeng Wang, Jun Hu, Yaxing Xu, Lizhao Chen, Ying Ju, Hongxia Fan, Bo Wu and Xiaoyu Chu. Their work appears in journals such as Protein & Cell, Journal of Virology, Scientific Reports, International Journal of Biological Macromolecules and Neurochemical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.